Work

Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.

Year: 2000

Type: article

Source: PubMed

Authors: S Arkin, F Blei, J Fetten, R Foulke, G S Gilchrist, M A Heisel, N Key, C T Kisker, C Kitchen, F E Shafer, P C Shah, D Strickland

Institutions: Icahn School of Medicine at Mount Sinai, New York University, Northwell Health, Mayo Clinic, University of Minnesota, University of Iowa, University of Florida, St. Christopher's Hospital for Children, John H. Stroger, Jr. Hospital of Cook County, St. Jude Children's Research Hospital

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2471212695

FWCI: 2.172

Cites:

Cited by: 69

Related to: 10